The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...
One of the lowest paid CEOs in pharma—and the only woman leading a top-tier giant—is set to receive up to $27.2 million in ...
As communication gaps in the US healthcare market widen, the emphasis on the need for credible information and patient ...
As they navigate a competitive job market, biopharma professionals are making four key interview mistakes, according to two ...
In this episode of Denatured, BioSpace's Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss life sciences investment and the potential for disruption.
While Kallyope’s drugs are mechanistically unique, the biotech is competing in a crowded space, with other therapies that ...
The company will push through with an accelerated approval application for odronextamab in follicular lymphoma, leaving ...
The move comes after President Donald Trump warned Big Pharma leaders that he would impose tariffs on them if they refuse to ...
The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr comes as the U.S. records its first ...
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果